Reglitazar

Drug Profile

Reglitazar

Alternative Names: JTT 501; PNU 182716; PNU 716; reglixane

Latest Information Update: 20 Jan 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Japan Tobacco
  • Developer Japan Tobacco; Pharmacia Corporation
  • Class Antihyperglycaemics; Insulin sensitisers
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 24 Oct 2002 Discontinued - Phase-II for Diabetes mellitus in USA (unspecified route)
  • 24 Oct 2002 Discontinued - Phase-II for Diabetes mellitus in Japan (unspecified route)
  • 08 Nov 2001 Reglitazar is the pINN for PNU 716
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top